Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome

NCT02890472 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT02890472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02890472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
December 31, 2020
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

22q11 deletion syndrome di george syndrome